Detalhe da pesquisa
1.
Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial.
Respir Med Res;
78: 100770, 2020 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32777737